USA-based Kailera Therapeutics today announced its launch as a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for the treatment of obesity and related conditions. 1 October 2024
US pharma giant Pfizer has announced a 1% decline in sales and a 3% increase in earnings per share this quarter, compared with the same period last year. 2 May 2017
A 22% increase in its net revenue was reported by US biotech Vertex Pharmaceuticals in its financial results for the first quarter of 2017 compared to the same period of 2016. 28 April 2017
US biotech firm Seattle Genetics has released first quarter financial results showing that 2017 revenues were $109 million, down slightly from the $111 million reported for the same period of 2016. 28 April 2017
French pharma major Sanofi pleased investors with a strong set of financial results for the first quarter of 2017 today, sending its shares 2.2% higher to 87.87 euros by mid-morning. 28 April 2017
US biotech Celgene slipped by 0.4% in four hours of trading on Thursday to $124.70 after reporting its first quarter financials, reflecting a mixed bag of results. 27 April 2017
In its first quarter financial results statement, Bristol-Myers Squibb has reported revenues of $4.9 billion, up 12% from the same period last year. 27 April 2017
Shares in London-listed AstraZeneca ticked down under 1% this morning as the company released first quarter results showing slower sales, in line with analyst forecasts, down 12% compared with the same period last year, at $5.4 billion. 27 April 2017
Germany’s Bayer has reported stronger than expected results for the first quarter of 2017, with 13.2 billion euros ($14.4 billion) in sales, a near 12% increase on the same period last year. 27 April 2017
Emma Walmsley, the new chief executive of GlaxoSmithKline, was able to point to some pretty impressive sales figures as she presented her first quarterly results at the UK drug major, helped partly by the weak pound. 26 April 2017
US pharma major Eli Lilly beat analysts’ estimates with the revenue and earnings per share (EPS) figures reported in its first quarter results, but markets perhaps paid more attention to its quarterly loss and reduced 2017 net earnings forecast. 25 April 2017
US biotech major Biogen has posted strong financial results, showing the company achieved $2.8 billion in sales this quarter. Investors are reacting warmly to the news, boosting the company’s share price nearly 5% in pre-market trading on the Nasdaq. 25 April 2017
They say it never rains but it pours, and for OncoMed Pharmaceuticals it has been more thunder and lightning than April showers this month with three damaging setbacks. 19 April 2017
As many as eight of the new therapeutics set to enter markets this year will cross the $1 billion annual sales threshold by 2021, according to a report from Clarivate Analytics. 10 April 2017
With the last set of 2016 financial results of a big-name pharma presented last week, it is possible – when they are viewed in a wider context – to gain some insight into the direction of the industry in analyzing the performance, outlook and pipeline of many of the major players. 10 April 2017
Shares in Hikma Pharmaceuticals are up over 7% today on the news that the Jordanian drugmaker beat expectations in its 2016 financial results statement. 15 March 2017
The level of investor interest in US-based biopharma company BeyondSpring is about to become apparent with the company’s listing on the Nasdaq stock market. 9 March 2017
The full-year and fourth quarter 2016 financial results statement from generics and specialty drugmaker Mylan seems to show the company has left its EpiPen troubles behind. 1 March 2017
Investors in Ireland-incorporated Perrigo probably did not know where to turn on Monday and Tuesday amid news on the company’s management, job cuts, divestment of royalty payment rights on a multiple sclerosis drug and its publication of bleak financial guidance. 1 March 2017
Paris-based asset manager Kurma Partners has raised 140 million euros ($154 million), successfully completing the first closing of Biofund IV 4 October 2024
Caliway Biopharmaceuticals has successfully completed its initial public offering, raising NT$6.4 billion ($206 million), the largest IPO in Taiwan's biotech industry to date. 3 October 2024
Shares of UK drug developer Hemogenyx Pharmaceuticals rose as much as 9% and closed up 5.9% at 1.70 pence yesterday on the news of a further investment from Prevail Partners. 3 October 2024
UK-based biotech Resolution Therapeutics has announced the completion of a £63.5 million ($76.8 million) series B financing round led by Syncona. 3 October 2024
UK-based biotech LoQus23 Therapeutics has closed a £35 million ($43 million) series A financing round, led by Forbion, with support from SV Health Investors' Dementia Discovery Fund and Novartis Venture Fund. 2 October 2024
USA-based Kailera Therapeutics today announced its launch as a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of next-generation therapies for the treatment of obesity and related conditions. 1 October 2024
Boston, USA-based biotech Aktis Oncology, which is targeting alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced the successful closing of an oversubscribed and upsized $175 million Series B financing. 1 October 2024
Chicago, USA-based ARCH Venture Partners revealed it has closed the ARCH Venture Fund XIII, a venture capital fund with more than $3 billion to support the founding and growth of early-stage biotechnology companies. 27 September 2024
USA-based biotech funder and incubator Flagship Pioneering yesterday unveiled Mirai Bio, a company pioneering the first open end-to-end platform for the biotech industry to enable the co-creation of fully optimized genetic medicines. 27 September 2024
The UK government has released a position paper outlining its vision for Framework Programme 10 (FP10), a successor to Horizon Europe, the EU's flagship research collaboration program. 26 September 2024
Italian biotech Genespire—which is developing off-the-shelf gene therapies for pediatric patients affected by genetic diseases—has announced the closing of a 46.6 million euros ($52 million) Series B financing. 25 September 2024
Healthcare plan provider Centivo has raised $75 million in equity and debt financing to support its goal of offering affordable care to employees and their families. 25 September 2024
Rare disease firm bluebird bio has announced a company-wide restructuring aimed at cutting costs by 20% and achieving quarterly cash flow break-even by the second half of 2025. 25 September 2024
Aptadir Therapeutics, a biotech company focused on RNA inhibitor-based therapies for cancer and genetic conditions, has launched with $1.6 million in pre-seed funding. 24 September 2024
Australian biotech company Telix Pharmaceuticals is to acquire USA-based RLS Radiopharmacies, expanding its manufacturing and distribution footprint in North America. 24 September 2024
British biotech Vicebio has secured $100 million in a series B funding round to accelerate the development of its next-generation vaccines against respiratory viruses. 23 September 2024
A pre-clinical stage biopharmaceutical group developing new medicines and treatments to treat blood and autoimmune disease and to bring the curative power of bone marrow transplantation to a greater number of patients suffering from otherwise incurable life-threatening diseases.
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news